• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交界性卵巢肿瘤的全球组织学分布:一项系统评价。

Histologic distribution of borderline ovarian tumors worldwide: a systematic review.

机构信息

Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea.

出版信息

J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8.

DOI:10.3802/jgo.2013.24.1.44
PMID:23346313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3549507/
Abstract

OBJECTIVE

The histologic types of borderline ovarian tumors (BOTs) exhibit striking differences in clinical behavior and prognosis. Yet, there is no information available on the histologic distribution of BOTs according to geographic region. The purpose of this study was to systematically review this issue worldwide.

METHODS

A comprehensive search of the literature was conducted using electronic databases. Studies were eligible if BOTs were investigated and the histologic distribution of the data was shown. The studies were grouped by geographic region and totaled by country.

RESULTS

Of 487 potentially relevant studies, 51 met our inclusion criteria, as follows: 8 studies from North America (2 countries); 26 studies from Europe (14 countries); 7 studies from the Middle East (3 countries); and 10 studies from East Asia (5 countries). The histologic distribution of BOTs was considerably different in different parts of the world, but follows specific patterns. In general, serous-type BOTs were the predominantly identified histology in North America, the Middle East, and Europe, while mucinous-type BOTs predominated in East Asia.

CONCLUSION

Significant geographic variation is evident among BOT histology in different parts of the world. More research is needed to understand this phenomenon.

摘要

目的

交界性卵巢肿瘤(BOT)的组织学类型在临床行为和预后方面存在显著差异。然而,目前尚无关于 BOT 组织学分布的地理区域信息。本研究的目的是在全球范围内系统地回顾这个问题。

方法

使用电子数据库进行了全面的文献检索。如果研究中调查了 BOT 并显示了数据的组织学分布,则符合纳入标准。研究按地理区域分组,并按国家进行汇总。

结果

在 487 篇潜在相关研究中,有 51 篇符合纳入标准,如下所示:北美(2 个国家)的 8 项研究;欧洲(14 个国家)的 26 项研究;中东(3 个国家)的 7 项研究;东亚(5 个国家)的 10 项研究。BOT 的组织学分布在世界不同地区存在显著差异,但遵循特定模式。一般来说,在北美、中东和欧洲,浆液型 BOT 是主要的组织学类型,而黏液型 BOT 则在东亚占主导地位。

结论

在世界不同地区,BOT 的组织学存在明显的地理差异。需要进一步研究以了解这种现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/6b3043134ff6/jgo-24-44-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/82ceac1006bf/jgo-24-44-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/6b3043134ff6/jgo-24-44-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/82ceac1006bf/jgo-24-44-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed5e/3549507/6b3043134ff6/jgo-24-44-g002.jpg

相似文献

1
Histologic distribution of borderline ovarian tumors worldwide: a systematic review.交界性卵巢肿瘤的全球组织学分布:一项系统评价。
J Gynecol Oncol. 2013 Jan;24(1):44-51. doi: 10.3802/jgo.2013.24.1.44. Epub 2013 Jan 8.
2
Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.丹麦交界性卵巢肿瘤后特定类型卵巢癌的风险:一项全国性研究。
Int J Cancer. 2020 Aug 15;147(4):990-995. doi: 10.1002/ijc.32864. Epub 2020 Jan 21.
3
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).卵巢交界性肿瘤:法国国家妇产科医师学会(CNGOF)指南
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:492-501. doi: 10.1016/j.ejogrb.2020.11.045. Epub 2020 Nov 20.
4
Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.交界性卵巢肿瘤:法国 CNGOF 指南。第 1 部分。流行病学、生物病理学、影像学和生物标志物。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101965. doi: 10.1016/j.jogoh.2020.101965. Epub 2020 Nov 4.
5
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.交界性卵巢肿瘤:法国 CNGOF 指南。第 2 部分。手术管理、随访、激素替代治疗、生育管理和保存。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2.
6
Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers.交界性卵巢肿瘤与其自身的浸润性癌和家族性风险相关。
Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1358-1363. doi: 10.1158/1055-9965.EPI-18-0503. Epub 2018 Jul 17.
7
Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.浆液性和黏液性交界性卵巢肿瘤 I 期患者的预后。
Int J Gynecol Cancer. 2012 Jun;22(5):770-7. doi: 10.1097/IGC.0b013e31824b4076.
8
Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.浆液性和黏液性卵巢交界性肿瘤中肿瘤标志物与临床病理特征的比较
Eur J Gynaecol Oncol. 2012;33(1):25-30.
9
The preoperative diagnosis of borderline ovarian tumors: a review of current literature.交界性卵巢肿瘤的术前诊断:当前文献回顾。
Arch Gynecol Obstet. 2012 Apr;285(4):1103-12. doi: 10.1007/s00404-011-2194-1. Epub 2011 Dec 31.
10
The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence.超声检查联合糖类抗原125和19-9检测在卵巢交界性肿瘤诊断及复发预测中的价值
Front Surg. 2023 Jan 6;9:951472. doi: 10.3389/fsurg.2022.951472. eCollection 2022.

引用本文的文献

1
The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes.卵巢交界性肿瘤各亚型的超声特征
J Ultrasound Med. 2025 Jun 30. doi: 10.1002/jum.16756.
2
Establishment of Two Novel Ovarian Tumor Cell Lines with Characteristics of Mucinous Borderline Tumors or Dedifferentiated Carcinoma-Implications for Tumor Heterogeneity and the Complex Carcinogenesis of Mucinous Tumors.建立两种具有黏液性交界性肿瘤或去分化癌特征的新型卵巢肿瘤细胞系——对肿瘤异质性及黏液性肿瘤复杂癌变过程的启示
Cancers (Basel). 2025 May 20;17(10):1716. doi: 10.3390/cancers17101716.
3
Fertility-sparing surgery versus radical surgery for micropapillary serous borderline ovarian tumours: a systematic review protocol.

本文引用的文献

1
Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.丹麦 1978-2006 年间交界性卵巢肿瘤发病率趋势。
Acta Obstet Gynecol Scand. 2011 Apr;90(4):305-12. doi: 10.1111/j.1600-0412.2010.01060.x. Epub 2011 Feb 18.
2
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).卵巢黏液性交界性肿瘤(不包括腹膜假黏液瘤)行保守性手术后的生育决定因素。
Hum Reprod. 2011 Apr;26(4):808-14. doi: 10.1093/humrep/deq399. Epub 2011 Jan 24.
3
Risk factors for recurrence of ovarian borderline tumors.
保留生育功能手术与激进手术治疗微乳头状浆液性交界性卵巢肿瘤:系统评价方案。
BMJ Open. 2024 Nov 12;14(11):e077503. doi: 10.1136/bmjopen-2023-077503.
4
Performing Routine Appendectomy in Mucinous Borderline Ovarian Tumours: An Experience of 15 Years From a Cancer Centre.在黏液性交界性卵巢肿瘤中实施常规阑尾切除术:来自一家癌症中心的15年经验
Cureus. 2024 Jul 28;16(7):e65580. doi: 10.7759/cureus.65580. eCollection 2024 Jul.
5
Borderline tumour recurrence: how quickly does the tumour grow?交界性肿瘤复发:肿瘤生长速度有多快?
BMJ Case Rep. 2024 May 9;17(5):e259501. doi: 10.1136/bcr-2023-259501.
6
Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.91 例浆液性和黏液性交界性卵巢肿瘤患者的临床病理特征和预后:一项对比研究。
Reprod Sci. 2023 Jun;30(6):1927-1937. doi: 10.1007/s43032-022-01114-7. Epub 2022 Dec 13.
7
Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.丹麦一项基于全国近 5000 例交界性卵巢肿瘤女性的研究显示,非卵巢癌的发病风险。
Int J Cancer. 2023 Apr 1;152(7):1370-1377. doi: 10.1002/ijc.34354. Epub 2022 Nov 23.
8
Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis.通过多学科综合分析识别的对浆液性卵巢肿瘤具有EMT效应的协同AHR结合途径
Biomedicines. 2021 Jul 22;9(8):866. doi: 10.3390/biomedicines9080866.
9
Risk factors that increase recurrence in borderline ovarian cancers.增加卵巢交界性肿瘤复发风险的因素。
Am J Transl Res. 2021 Jul 15;13(7):8438-8449. eCollection 2021.
10
Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics.通过整合多基因分析,认识到交界性卵巢肿瘤发病机制中的免疫功能失调和代谢途径功能障碍。
Int J Mol Sci. 2021 Apr 15;22(8):4105. doi: 10.3390/ijms22084105.
卵巢交界性肿瘤复发的危险因素。
Gynecol Oncol. 2011 Mar;120(3):480-4. doi: 10.1016/j.ygyno.2010.11.016. Epub 2010 Dec 10.
4
Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.在汤姆贝克癌症中心有十年的卵巢交界性肿瘤管理经验。
Arch Gynecol Obstet. 2011 Sep;284(3):731-5. doi: 10.1007/s00404-010-1713-9. Epub 2010 Oct 21.
5
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).一项大型回顾性卵巢黏液性交界性肿瘤(不包括腹膜假黏液瘤)系列的预后因素研究。
Ann Surg Oncol. 2011 Jan;18(1):40-8. doi: 10.1245/s10434-010-1293-8. Epub 2010 Aug 25.
6
Serous and mucinous borderline ovarian tumors: are there real differences between these two entities?浆液性和黏液性交界性卵巢肿瘤:这两种实体之间真的存在差异吗?
Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):188-92. doi: 10.1016/j.ejogrb.2010.07.024. Epub 2010 Aug 21.
7
Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?全面淋巴结清扫术:对于交界性上皮性卵巢肿瘤的治疗是否必要?
Arch Gynecol Obstet. 2011 Apr;283(4):879-84. doi: 10.1007/s00404-010-1539-5. Epub 2010 Jun 13.
8
Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature.123 例交界性卵巢肿瘤患者术前 CA-125 水平:回顾性分析及文献复习。
Int J Gynecol Cancer. 2009 Nov;19(8):1335-8. doi: 10.1111/IGC.0b013e3181a83e04.
9
Systematic evaluation of the intraoperative tumor pattern in patients with borderline tumor of the ovary.系统评估卵巢交界性肿瘤患者术中肿瘤模式。
Int J Gynecol Cancer. 2009 Dec;19(9):1550-5. doi: 10.1111/IGC.0b013e3181a84699.
10
Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.卵巢交界性肿瘤术中冰冻切片临床分析。
J Gynecol Oncol. 2009 Sep;20(3):176-80. doi: 10.3802/jgo.2009.20.3.176. Epub 2009 Sep 30.